BiotechTube
Home/Pipeline/Potential Diagnostic Development

Potential Diagnostic Development

Endometriosis

ResearchActive

Key Facts

Indication
Endometriosis
Phase
Research
Status
Active
Company
Juneau Biosciences

About Juneau Biosciences

Juneau Biosciences is a private, pre-revenue biotech company dedicated to advancing women's health through genetic research and product development. Its core focus is on identifying genetic markers for endometriosis to create diagnostic tools and potential therapeutics, leveraging a population-based gene mapping approach. The company is actively recruiting participants and physicians for its genetic studies, indicating a research-heavy, early-stage operational model. Its success hinges on validating genetic discoveries and translating them into clinically viable products.

View full company profile

Therapeutic Areas

EndometriosisInfertility

Other Endometriosis Drugs

DrugCompanyPhase
Promarker™EndoProteomics InternationalLate‑stage validation
EV‑EndoCarthericsPreclinical
Endometriosis ProgramCyclana BioDiscovery
Endometriosis Genetic StudyJuneau BiosciencesDiscovery
Endometriosis Discovery ProgramMetri BioDiscovery
Endometriosis Test SuiteHeranova LifesciencesPre-clinical
EndomTestKephera DiagnosticsCommercial (LDT)
ENDO-205EndoCyclic TherapeuticsPhase 1
Undisclosed ImmunotherapyApheon BiosciencePreclinical
FMCFimmCytePre-clinical
ABC-201AbcelyPreclinical
ERβ Modulator ProgramCadenza BioPreclinical